Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes

American Journal of Pathology

Volumn 163, Issue 2, 2003, Pages 381-385

  Luo, Honglin ^a   Zhang, Jingchun ^b   Cheung, Caroline ^b   Suarez, Agripina ^b   McManus, Bruce M ^b   Yang, Decheng ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CELL CYCLE PROTEIN; CYCLIN D1; LACTACYSTIN; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN; VIRUS RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; HEART DILATATION; HEART MUSCLE CELL; MOUSE; MYOCARDITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; RNA TRANSCRIPTION; VIRUS REPLICATION;

EID: 0041344358     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63667-X     Document Type: Article

References (23)

1. McManus BM, Chow LH, Radio SJ, Tracy SM, Beck MA, Chapman NM, Klingel K, Kandolf R: Progress and challenges in the pathological diagnosis of myocarditis Eur Heart J 1991, 12:18-21
2. Martino TA, Liu P, Sole MJ: Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 1994, 74:182-188
3. Myung J, Kim KB, Crews CM: The ubiquitin-proteasome pathway and proteasome inhibitors. Med Res Rev 2001, 21:245-273
4. Ciechanover A: The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J 1998, 17:7151-7160
5. Hochstrasser M: Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol 1995, 7:215-223
6. Hicke L: Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol 2001, 2:195-201
7. Luo H, Zhang J, Dastvan F, Yanagawa B, Reidy MA, Zhang HM, Yang D, Wilson JE, McManus BM: Ubiquitin-dependent proteolysis of cyclin D1 is associated with coxsackievirus-induced cell growth arrest. J Virol 2003, 77:1-9
8. Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ: HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 1998, 95:2979-2984
9. Anderson DR, Wilson JE, Carthy CM, Yang D, Kandolf R, McManus BM: Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis. J Virol 1996, 70:4632-4645
10. Patick AK, Binford SL, Brothers MA, Jackson RL, Ford CE, Diem MD, Maldonado F, Dragovich PS, Zhou R, Prins TJ, Fuhrman SA, Meador JW, Zalman LS, Matthews DA, Worland ST: In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob. Agents Chemother 1999, 43:2444-2450
11. Hu X, Bryington M, Fisher AB, Liang X, Zhang X, Cui D, Datta I, Zuckerman KS: Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest. J Biol Chem 2002, 277:16528-16537
12. Adams J: Development of the proteasome inhibitor PS-341. Oncologist 2002, 7:9-16
13. Lee DH, Goldberg AL: Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 1998, 8:397-403
14. Patnaik A, Chau V, Wills JW: Ubiquitin is part of the retrovirus budding machinery. Proc Natl Acad Sci USA 2000, 97:13069-13074
15. Strack B, Calistri A, Accola MA, Palu G, Gottlinger HG: A role for ubiquitin ligase recruitment in retrovirus release. Proc Natl Acad Sci USA 2000, 97:13063-13068
16. Schubert U, Ott DE, Chertova EN, Welker R, Tessmer U, Princiotta MF, Bennink JR, Krausslich HG, Yewdell JW: Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl Acad Sci USA 2000, 97:13057-13062
17. Lee H, Lee YH, Huh YS, Moon H, Yun Y: X-gene product antagonizes the p53-mediated inhibition of hepatitis B virus replication through regulation of the pregenomic/core promoter. J Biol Chem 1995, 270: 31405-31412
18. Duan L, Ozaki I, Oakes JW, Taylor JP, Khalili K, Pomerantz RJ: The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication. J Virol 1994, 68:4302-4313
19. Luo H, Yanagawa B, Zhang J, Luo Z, Zhang M, Esfandiarei M, Carthy C, Wilson JE, Yang D, McManus BM. Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signalling pathway. J Virol 2002, 76:3365-3373
20. Orlowski RZ, Small GW, Shi YY: Evidence that inhibition of p44/p42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitor-mediated apoptosis. J Biol Chem 2002, 277:27864-27871
21. Feuer R, Mena I, Pagarigan R, Slifka MK, Whitton JL: Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J Virol 2002, 76:4430-4440
22. Kumeda SI, Deguchi A, Toi M, Omura S, Umezawa K: Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells. Anticancer Res 1999, 19:3961-3968
23. Fenteany G, Standaert RF, Reichard GA, Corey EJ, Schreiber SL: A β-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line. Proc Natl Acad Sci USA 1994, 91:3358-3362